A common medical error: lung cancer misdiagnosed as sputum negative tuberculosis
- PMID: 19640168
A common medical error: lung cancer misdiagnosed as sputum negative tuberculosis
Abstract
Objective: To emphasize that delay in diagnosis of lung cancer can be caused by the wrong diagnosis of tuberculosis (TB) in TB endemic countries. This is of major concern as early-diagnosis of lung cancer can increase the chance of tumor resectability and timely chemo-radiotherapy may provide better quality of life.
Methods: Proven lung cancer patients, who had received anti-tubercular treatment (ATT) since onset of current symptoms, were studied retrospectively during the period of Nov-07 to Nov-08. DATA-SOURCE: Patient interview and medical records.
Results: Total of 14 out of 70 patients received wrong diagnosis of TB and had received ATT (male-12, female-2; mean age 58.07-/+6.81; Non Small Cell Lung Cancer (NSCLC) -12, Small Cell Lung Cancer (SCLC) -2), 12 were smokers with median smoking pack-years of 44(15 to 112). Pre-referral sputum acid fast bacilli (AFB) was done in only 3 out of these 14 patients and sputum AFB was negative in these 3 patients. ATT was started on the basis of chest X-ray finding and clinical symptoms. Mean duration of ATT taken was 4.46-/+3.15 months.
Conclusion: Due to high TB prevalence and radiological similarities, a large number of lung cancer patients initially get wrongly treated for TB. Also, clinicians associate lung cancer with high case-fatality and start ATT without detailed investigation. Altogether, this leads to delay in diagnosis and progression of disease.
Similar articles
-
Delays during the diagnostic evaluation and treatment of lung cancer.Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):453-6. Asian Pac J Cancer Prev. 2009. PMID: 19640190
-
Squamous cell lung cancer in a male with pulmonary tuberculosis.Pneumonol Alergol Pol. 2015;83(4):298-302. doi: 10.5603/PiAP.2015.0049. Pneumonol Alergol Pol. 2015. PMID: 26166791
-
Results of diagnostic dilemma between lung cancer and sputum negative pulmonary tuberculosis: a retrospective study.J Indian Med Assoc. 2012 Dec;110(12):898-900. J Indian Med Assoc. 2012. PMID: 23936954
-
Exhaustive Review on Lung Cancers: Novel Technologies.Curr Med Imaging Rev. 2019;15(9):873-883. doi: 10.2174/1573405615666181128124528. Curr Med Imaging Rev. 2019. PMID: 32013812 Review.
-
Management of co-existent tuberculosis and lung cancer.Lung Cancer. 2018 Aug;122:83-87. doi: 10.1016/j.lungcan.2018.05.030. Epub 2018 Jun 1. Lung Cancer. 2018. PMID: 30032851 Review.
Cited by
-
Factors influencing the timeliness of care for patients with lung cancer in Bangladesh.BMC Health Serv Res. 2023 Mar 16;23(1):261. doi: 10.1186/s12913-023-09154-8. BMC Health Serv Res. 2023. PMID: 36927788 Free PMC article.
-
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing.Adv Ther. 2019 Apr;36(4):766-785. doi: 10.1007/s12325-019-00903-y. Epub 2019 Mar 12. Adv Ther. 2019. PMID: 30864106
-
What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis.Clin Infect Dis. 2019 Jan 1;68(1):150-156. doi: 10.1093/cid/ciy544. Clin Infect Dis. 2019. PMID: 29982375 Free PMC article.
-
The Applications of ELISpot in the Identification and Treatment of Various Forms of Tuberculosis and in the Cancer Immunotherapies.Methods Mol Biol. 2024;2768:51-58. doi: 10.1007/978-1-0716-3690-9_4. Methods Mol Biol. 2024. PMID: 38502387
-
Molecular profile of non-small cell lung cancer in a predominantly Black African population in Kenya: A single institution review.Transl Oncol. 2025 May;55:102348. doi: 10.1016/j.tranon.2025.102348. Epub 2025 Mar 19. Transl Oncol. 2025. PMID: 40112503 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical